“Ozempic face”: what it is and what causes it

The face contains discrete fat compartments that give it contour. Lose body fat quickly and substantially and those compartments shrink along with everything else. Skin that has lost its underlying volume — particularly skin with less elasticity, which is to say older skin — does not retract at the same rate. The result reads as gauntness, hollowing around the temples and cheeks, and looser skin along the jaw.

None of this is specific to semaglutide. It follows rapid weight loss after bariatric surgery, after aggressive dieting, and after illness. What is new is the number of people losing 15–20% of their body weight in a year, which is what these drugs made ordinary.

The dermatology literature has responded practically rather than dramatically: a 2026 review discusses the aesthetic use of poly-L-lactic acid and hyaluronic acid fillers in medication-driven weight loss, treating facial volume loss as a predictable consequence to be managed.

If the mechanism is the rate and magnitude of fat loss, then the levers are the rate and magnitude of fat loss — and whatever preserves lean tissue along the way. A slower titration, a maintenance dose below the maximum, adequate protein and resistance training during the deficit: these are the standard responses to any rapid weight loss, and they are reasonable here for the same reasons.

It should be said plainly that none of this has been tested as an intervention against facial volume loss on GLP-1 drugs specifically. It is mechanistic reasoning, not trial evidence, and this page will not pretend otherwise.

Age and baseline skin elasticity matter, and neither is modifiable. So does how much weight is lost in total, which is usually the point of taking the drug.

The same physiology, relabelled by anatomical region. Subcutaneous fat is lost from the buttocks, the breasts, and the hands, and the skin follows imperfectly. Each variant gets a name, and each name repeats the same error of attributing to the drug what belongs to the loss.

A related coinage in this vocabulary is food noise — and that one describes something the drug genuinely does. It is worth distinguishing the two: “food noise” names a real pharmacological effect on the reward system, now taken seriously enough to attract methodological papers of its own. “Ozempic face” names a consequence of losing weight.